StarCaps diuretic recall expanded

By Shane Starling

- Last updated on GMT

The US recall of StarCaps weight loss supplements has been expanded after it was determined by the manufacturer that further batches of end products and raw materials were contaminated with a banned diuretic.

The voluntary recall highlights quality control issues, but Marc Ullman, legal counsel for the marketer, Balanced Health, said the blame should fall at least in part on its supplier, in this case a Peruvian company that produced the pre-mixed formula.

“The problem lies in the fact that companies don’t test for this substance because it is only a problem in the professional sports arena,”​ Ullman told NutraIngredients-USA.com.

“We are considering legal action against them. We may be looking at a situation where there has been a fraud committed against Balanced Health through this adulteration. At the same time Balanced Health acknowledges its responsibilities under the Food and Drug Act which is why they have undertaken these recalls.”

Ullman said it was the first time Balanced Health had encountered contamination problems. It was in the process of locating a new domestic supplier of the weight loss pre-mix blend.

The recall was sparked by professional football players testing positive to the diuretic, bumetanide, which then prompted Balanced Health to conduct further testing. When these tests also came back positive the company recalled the products.

In conjunction with the Food and Drug Administration (FDA) it has subsequently recalled two batches dating as far back as March, 2006, as well as quarantining a batch of raw materials yet to see the manufacturing process.

Quality control

Ullman said it was not necessarily a failing of quality control for contaminated batches more than two-years-old to go undetected.

“Look at how long melamine was in the food supply for before it was detected,”​ he said. “Unless you are specifically testing for an ingredient you are not going to find it. There was no need to be screening for bumetanide.It wasn’t a sports product, it was a weight loss product for women.”

However the National Football League said it had warned front officers, trainers and players unions in December 2006 about the supplements and had added Balanced Health to its list of prohibited dietary supplement companies.

At least one the NFL players banned because of consuming StarCaps was suing Balanced Health, and the case was due to be heard early in 2009.

Bumetanide was found in the StarCaps dietary supplements at a level 0.8mg per capsule.

Bumetanide can have the side effect of fluid and electrolyte loss and raised uric acid concentrations. Other symptoms include hypotension (low blood pressure) and fainting (syncope).

Ullman speculated it was used by suppliers because it was cheaper than “materials that were meant to be supplied”.

NutraIngredients-USA.com was unable to determine the name of the Peruvian supplier by the time of publication.

Related topics Regulation Energy Weight management

Related news

Related products

show more

MOROSIL:INGREDIENT OF THE YEAR

MOROSIL:INGREDIENT OF THE YEAR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Mar-2024 | Product Brochure

MOROSIL™ has won as Ingredient of the Year in the category Weight Management at 2023 Nutraingredient USA. MOROSIL ™ is a standardized extract derived from...

In Weight Management Go Beyond with Slendacor®

In Weight Management Go Beyond with Slendacor®

Content provided by PLT Health Solutions | 22-Feb-2024 | White Paper

Slendacor® is a synergistic, patented formulation of three standardized herbal extracts: turmeric (Curcuma longa), moringa (Moringa oleifera) and curry...

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 22-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

Polyphenol extracts as weight management catalysts

Polyphenol extracts as weight management catalysts

Content provided by DolCas Biotech, LLC. | 18-Jan-2024 | White Paper

Viable natural product options for "healthy weight management" in the age of Ozempic and other GLP-1 inhibitors will require targeted innovations...

Related suppliers

Follow us

Products

View more

Webinars